NHL | Jotup

C4 Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Recent Business Highlights

Retrieved on:

Thursday, February 22, 2024

WATERTOWN, Mass., Feb. 22, 2024 (GLOBE NEWSWIRE) -- C4 Therapeutics, Inc. (C4T) (Nasdaq: CCCC), a clinical-stage biopharmaceutical company dedicated to advancing targeted protein degradation science, today reported financial results for the year ended December 31, 2023, as well as recent business updates.

Key Points:

As of February 2024, three escalation cohorts are complete and dose escalation continues with a fourth dose level currently enrolling.
In December 2023, C4T and Merck entered into a license and research collaboration to discover and develop degrader antibody conjugates.
Net loss per share for the year ended December 31, 2023 was $2.67, compared to $2.62 for the year ended December 31, 2022.
Cash Position and Financial Guidance: Cash, cash equivalents and marketable securities as of December 31, 2023 were $281.7 million, compared to $337.1 million as of December 31, 2022.

Evolv Express® Named “Best in Sports Technology” 2024 by Sports Business Journal

Retrieved on:

Thursday, March 7, 2024

Later, at the end of an awards ceremony attended by hundreds of executives, technologists, journalists, and other sports industry leaders, Express was further honored as the “Best in Sports Technology” for 2024.

Key Points:

Later, at the end of an awards ceremony attended by hundreds of executives, technologists, journalists, and other sports industry leaders, Express was further honored as the “Best in Sports Technology” for 2024.
The second honor put Express first among a total of 34 nominees in six categories, which in turn, were drawn from 271 submissions.
To date, Evolv Express is deployed at almost 50 major pro and collegiate sports venues in the United States and England.
Sports Business Journal (SBJ) is the sports industry’s business media source of record.

Caesars Sportsbook and National Hockey League Renew Partnership

Retrieved on:

Thursday, March 7, 2024

Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”) and the National Hockey League (NHL®) today announced a renewal of their United States partnership.

Key Points:

Caesars Entertainment, Inc. (NASDAQ: CZR) (“Caesars”) and the National Hockey League (NHL®) today announced a renewal of their United States partnership.
This renewed agreement also provides access to VIP experiences for members of the industry-leading customer loyalty program, Caesars Rewards ®, and opportunities for visibility for Caesars Sportsbook and Caesars Rewards on national NHL broadcasts of Stanley Cup Playoff games in select Caesars markets.
Additionally, Caesars will enjoy continued use of NHL team logos and imagery on the Caesars Sportsbook app and access to League Alumni and the Stanley Cup® for appearances.
NHL, the NHL Shield, and the word mark and image of the Stanley Cup are registered trademarks of the National Hockey League.

Law Firm of Cerri, Boskovich & Allard Files a Lawsuit Over the Alleged Sexual Abuse of a San Jose Jr. Sharks Hockey Player

Retrieved on:

Thursday, March 7, 2024

The law firm of Cerri, Boskovich & Allard has filed a lawsuit alleging that a San Jose Jr.

Key Points:

The law firm of Cerri, Boskovich & Allard has filed a lawsuit alleging that a San Jose Jr.
Sharks hockey player was sexually abused due to the negligence of Sharks Sports & Entertainment, LLC and its subsidiary, Sharks Ice, LLC.
Sharks Sports and Entertainment is a privately held company that owns the San Jose Sharks and several sports-related properties throughout the Bay Area.
Whitmer, the lawsuit claims, would take the young victim alone into the locker room at Sharks Ice, the ice-skating facility and the official training facility of the NHL's San Jose Sharks.

Melbourne Cricket Club Takes Evolv Technology Down Under

Retrieved on:

Wednesday, March 6, 2024

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.

Key Points:

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based screening to create safer experiences, today announced its partnership with Melbourne Cricket Club (MCC), the largest – and one of the oldest - sports clubs in Australia.
Managed by Melbourne Cricket Club, Melbourne Cricket Ground is a sports stadium in Yarra Park, Melbourne, Victoria.
Melbourne Cricket Club was introduced to Evolv by Convergint, which supplies Melbourne Cricket Ground with its other security technology.
“We were looking for a more efficient entry experience for guests coming to the Melbourne Cricket Ground,” said Rey Sumaru, general manager of IT & innovation for the Melbourne Cricket Club.

Innate Pharma: First Patient dosed in Phase 1/2 study of IPH6501 in relapsed /refractory B-Cell non-Hodgkin’s Lymphoma

Retrieved on:

Wednesday, March 6, 2024

Oncology, Health, Clinical Trials, General Health, Pharmaceutical, Biotechnology, CD20, IPH, CD16, NHL, NCR1, Relapse, IPHA, Safety, Therapy, Patient, NK, Euronext Paris, Pharmaceutical industry

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the first patient was dosed in its Phase 1/2 multicenter trial ( NCT06088654 ), investigating the safety and tolerability of IPH6501 in patients with Relapsed and/or Refractory CD20-expressing B-cell Non-Hodgkin’s Lymphoma (NHL).

Key Points:

Innate Pharma SA (Euronext Paris: IPH; Nasdaq: IPHA) (“Innate” or the “Company”) today announced the first patient was dosed in its Phase 1/2 multicenter trial ( NCT06088654 ), investigating the safety and tolerability of IPH6501 in patients with Relapsed and/or Refractory CD20-expressing B-cell Non-Hodgkin’s Lymphoma (NHL).
The study is planned to enroll up to 184 patients.
“We are pleased to announce the dosing of a first patient in this Phase 1/2 study evaluating IPH6501, our proprietary ANKET® asset and the first tetraspecific NK Cell Engager to enter the clinic.” commented Dr Sonia Quaratino, Chief Medical Officer at Innate Pharma.
In this context, IPH6501 represents an innovative option for the treatment of patients with R/R B-cell non-Hodgkin’s lymphomas and has the potential to fulfil a large unmet need.”

Evolv Technology and Footprint Center Announce Partnership

Retrieved on:

Tuesday, March 5, 2024

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced a partnership with Footprint Center to use its state-of-the-art Evolv Express ® screening solution.

Key Points:

Evolv Technology (NASDAQ: EVLV), the leading security technology company pioneering AI-based weapons detection to create safer experiences, today announced a partnership with Footprint Center to use its state-of-the-art Evolv Express ® screening solution.
“We are excited to partner with Footprint Center to achieve a more sophisticated security posture and elevated fan experience,” said John Baier, Evolv’s vice president of sports.
Footprint Center, home of the Phoenix Suns and Phoenix Mercury, is one of the first NBA arenas to use Evolv Technology, integrated during the start of the 2023-24 season.
Footprint Center joins a growing roster of facilities and sports teams using Evolv Technology for weapons detection .

Brightcove to Power MotoAmerica’s First Global Livestream of the Daytona 200

Retrieved on:

Tuesday, March 5, 2024

As the official streaming provider for MotoAmerica, Brightcove will power the live and video-on-demand (VOD) capabilities of the MotoAmerica Live+ streaming service, which will exclusively broadcast the upcoming 82nd running of the Daytona 200 (March 7-9, 2024).

Key Points:

As the official streaming provider for MotoAmerica, Brightcove will power the live and video-on-demand (VOD) capabilities of the MotoAmerica Live+ streaming service, which will exclusively broadcast the upcoming 82nd running of the Daytona 200 (March 7-9, 2024).
“Delivering quality live and on-demand streaming experiences is essential for today’s sports and entertainment organizations to reach and engage their audiences effectively,” said Marc DeBevoise, CEO of Brightcove.
“In response, we decided to collaborate with Brightcove to offer our fans the upgraded experience they have been asking for.
Partnering with Brightcove ensures that both current and new fans of MotoAmerica can enjoy the best viewing experience possible.

johnnie-O Announces the Launch of the Brand’s First-Ever Women’s Capsule Collection

Retrieved on:

Friday, March 1, 2024

View the full release here: https://www.businesswire.com/news/home/20240301149652/en/

Key Points:

View the full release here: https://www.businesswire.com/news/home/20240301149652/en/
johnnie-O announces the launch of the brand's first-ever women's capsule collection.
(Photo: Business Wire)
The women’s capsule collection has been thoughtfully curated to blend comfort with everyday essentials through various styles, including transitional dresses, on-trend matching sets, and luxuriously soft sweaters.
The capsule collection embodies the laid-back johnnie-O spirit while bringing timeless style to luxe pieces, from garment-washed French terry to ultra-soft knits and wovens.
The brand also recently launched an NHL Collection for men and boys, in addition to its MLB Collection, NCAA Collegiate Collection, and select PGA Tour and USGA Golf Tournament Collections.

SeatGeek Announces Next Fan Up Product Release Ahead of MLB Season

Retrieved on:

Monday, February 26, 2024

In anticipation of the MLB season, SeatGeek is introducing Next Fan Up , its new product release that reimagines the ticket-selling experience.

Key Points:

In anticipation of the MLB season, SeatGeek is introducing Next Fan Up , its new product release that reimagines the ticket-selling experience.
(Graphic: Business Wire)
A fall 2023 SeatGeek survey of season ticket members found that 45% were concerned about having paid for games they wouldn’t be able to attend.
“Our goal for Next Fan Up is to make the ticket-selling experience easier,” said Russ D'Souza, co-founder of SeatGeek.
“Working with SeatGeek has opened up new avenues for us to enhance the fan experience, and fan selling is a part of that.